Pharming Group N.V.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $138.5M | $255.9M | $74.3M |
| FY2020 | $235.0M | $418.5M | $205.2M |
| FY2021 | $204.4M | $397.3M | $191.9M |
| FY2022 | $221.2M | $425.8M | $207.3M |
| FY2023 | $244.1M | $462.9M | $61.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $138.5M | $255.9M | $74.3M |
| FY2020 | $235.0M | $418.5M | $205.2M |
| FY2021 | $204.4M | $397.3M | $191.9M |
| FY2022 | $221.2M | $425.8M | $207.3M |
| FY2023 | $244.1M | $462.9M | $61.7M |